Jill M. Rafalko

Age at cancer diagnosis by breed, weight, sex, and cancer type in a cohort of more than 3,000 dogs: Determining the optimal age to initiate cancer screening in canine patients

Jill M. Rafalko, Kristina M. Kruglyak, Angela L. McCleary‐Wheeler et al. · PLoS ONE · 2023 · 70 citations · Full text

Working Dog, Diagnosis, Pathology +18

Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study

Andi Flory, Kristina M. Kruglyak, John A. Tynan et al. · PLoS ONE · 2022 · 52 citations · Full text

A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory

Brittany Dyr, Theresa Boomer, Eyad A. Almasri et al. · PLoS ONE · 2019 · 25 citations · Full text

Genetic Testing, Fertility, Sequenom Laboratories +24

Genome-wide cell-free DNA screening: a focus on copy-number variants

Jill M. Rafalko, Erica Soster, Samantha Caldwell et al. · Genetics in Medicine · 2021 · 24 citations · Full text

Impact of mosaicism ratio on positive predictive value of <scp>cfDNA</scp> screening

Jill M. Rafalko, Samantha Caldwell, John A. Tynan et al. · Prenatal Diagnosis · 2020 · 19 citations · Full text